Biomarkers in Cancer

Deputy Editor in Chief

The deputy editor in chief provides support to the editor in chief on editorial decision-making, and is responsible for editorial-decisions when the editor in chief is unavailable or has declared a conflict of interest. 

Michael Linnebacher, PhD

Dr Michael Linnebacher is an immunologist and molecular biologist trained in Saarbrücken, Homburg and Heidelberg. He received his Ph.D. in 2001 from the University of Karlsruhe. In 2005 he went to Rostock, where he currently leads a group working on molecular oncology and immunotherapy with a strong focus on tissue banking and establishment of individual models of disease. Additional research interests focus on the development and evaluation of novel diagnostic assays and therapeutic strategies basing on neoantigens derived from mutations and reactivated endogenous retroviral sequences. 

---

Editorial Board Members

The editorial board is the journal's primary source of peer reviewers and members occasionally provide assistance to the editor in chief.  The editor in chief welcomes applications from suitable candidates to join the editorial board.  Further information on the editorial board is available here.

Hafiz Ahmed, PhD
Assistant Professor, Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine and Greenebaum Cancer Center, Baltimore, MD, USA

Graham Ball, PhD, BSc, FRSB
Professor of Bioinformatics, Science and Technology, Nottingham Trent University, Nottingham, UK

Alison Banham, MA, DPHil, FRCPath
Professor in Haemato-Oncology, Nuffield Department of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford, Oxford, UK

Ancha Baranova, PhD, DSci
Associate Professor, Molecular and Microbiology Department, School of Systems Biology,  College of Science, George Mason University, Fairfax, VA, USA

Ashish Chintakuntlawar, MD, PhD
Fellow, Mayo Clinic, Rochester, MN, USA

Jayanta K Das, PhD
Research Assistant Professor, Department of Environmental and Occupational Health, Florida International University, Miami, FI 33199, USA

Luca Filippi, MD
Nuclear Medicine Physician, Department of Nuclear Medicine, Santa Maria Goretti Hospital, Latina, Italy

Gilles Guillemin, PhD, JP
Professor, Australian School of Advanced Medicine, Macquarie University; Co-Director, MND and Neurodegenerative diseases Research Centre, Macquarie University, Sydney, Australia

Oliver W. Hakenberg, MD, PhD, FEBU
Professor and Chairman, Urology, University Hospital, University of Rostock, Rostock, Germany

Kam Man Hui, PhD
Professor, Cancer Genomics, Division of Cellular and Molecular Research, National Cancer Centre Singapore, Singapore

Shahram Kordasti, MD, PhD
Lecturer, Department of Haematological Medicine, King's College London, London, UK

Jon Amund Kyte, MD, PhD
MD, Department of Oncology, The Cancer Clinic, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway

Cindy Lee, PhD
Consultant Haematologist, Haematology, SA Pathology, Royal Adelaide Hospital, Adelaide, Australia

Wen-Rong Lie, PhD
Principal Scientist, Research and Development, Bioscience, EMD Millipore, St Charles, MO, USA

Aija Linē , PhD
Group Leader, Cancer Biomarker Group, Latvian Biomedical Research and Study Centre, Riga, Latvia

Ken Mills, PhD
Professor, Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, UK

Steven R. Myers, PhD
Professor of Pharmacology and Toxicology, Department of Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville, KY, US

Alistair Noble, PhD
Senior Lecturer, Department of Asthma, Allergy & Respiratory Science, School of Medicine, King’s College London, London, UK

Adam Paige, PhD
Senior Lecturer in Biomedical Science, Department of Life Sciences, University of Bedfordshire, Park Square, Luton LU1 3JU

Bhuminder Singh, PhD
Research Scientist, Department of Medicine, Vanderbilt University, Nashville, Tennessee, USA

Evelien Smits, PhD
Assistant Professor, Center for Oncological Research and Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium

Masatoshi Tagawa, MD, PhD
Head, Division of Pathology and Cell Therapy, Chiba Cancer Center Research Institute, Chiba, Japan

Mark Tangney, PhD
Principal Investigator, Cork Cancer Research Centre, University College Cork, Cork, Ireland

James Willey, MD
Professor, Medicine and Pathology, University of Toledo Health Sciences Campus, Toledo, OH, USA

Dexian Zheng, PhD
Professor, Department of Biochemistry and Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

Xianfeng Zhou, PhD
Assistant Professor, Cener for Molecular Biology of Oral Diseases, University of Illinois at Chicago, Chicago, IL, USA

Zheying Zhu, PhD
Senior Lecturer in Pharmacology, Department of Life Sciences, University of Bedfordshire, UK